Sky-high OxyContin sales are threatened by reports of abuse, prosecutors investigate a claim central to OxyContin marketing, and Finnix begins to question the safety of the drug.
Comentarios
No hay comentarios
Sé el primero en comentar, tu opinión es importante.
No hay más episodios disponibles.
